ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

VIRI Virios Therapeutics Inc

0.443
-0.0128 (-2.81%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Virios Therapeutics Inc VIRI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0128 -2.81% 0.443 13:00:07
개장가 저가 고가 종가 전일 종가
0.4609 0.44 0.4749 0.4695 0.4558
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/03/202422:15GLOBEVirios Therapeutics Announces Publication of International..
09/03/202407:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
07/03/202406:30EDGAR2Form 8-K - Current report
01/03/202423:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/02/202423:25EDGAR2Form 8-K - Current report
29/02/202423:15GLOBEVirios Therapeutics Announces Fourth Quarter and Full Year..
29/02/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202402:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202402:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202423:15GLOBEVirios Therapeutics Issues Shareholder Letter..
28/02/202406:15EDGAR2Form 8-K - Current report
03/02/202406:31EDGAR2Form DEF 14A - Other definitive proxy statements
22/01/202423:33EDGAR2Form PRE 14A - Other preliminary proxy statements
22/01/202423:00GLOBEVirios Therapeutics Announces Plans to Advance..
03/01/202421:05EDGAR2Form 8-K - Current report
02/01/202421:05GLOBEVirios Therapeutics, Inc. Reaches Alignment with FDA on..
13/11/202323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202321:20EDGAR2Form 8-K - Current report
13/11/202321:05GLOBEVirios Therapeutics Announces Third Quarter 2023 Financial..
07/11/202321:29EDGAR2Form 8-K - Current report
06/11/202321:05GLOBEVirios Therapeutics to Report Third Quarter 2023 Financial..
02/11/202320:05EDGAR2Form 8-K - Current report
12/10/202320:05GLOBEVirios Therapeutics to Present at the ThinkEquity Conference..
18/09/202320:16EDGAR2Form 8-K - Current report
18/09/202320:05GLOBEVirios Therapeutics Announces Termination of At-The-Market..
12/09/202320:05GLOBEVirios Therapeutics CEO Greg Duncan to Present at the..
23/08/202304:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/08/202320:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/08/202320:05GLOBEVirios Therapeutics Announces Halt to At-The-Market Offering..
11/08/202321:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:15EDGAR2Form 8-K - Current report
10/08/202320:05GLOBEVirios Therapeutics Announces Second Quarter 2023 Financial..
09/08/202320:15EDGAR2Form 8-K - Current report
09/08/202320:05GLOBEVirios Therapeutics Announces Plans to Advance Lead..
04/08/202305:05GLOBEVirios Therapeutics to Report Second Quarter 2023 Financial..
17/07/202320:15EDGAR2Form 8-K - Current report
17/07/202320:05GLOBEVirios Therapeutics Announces Positive Data Demonstrating..
15/07/202305:25EDGAR2Form 8-K - Current report
15/07/202305:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/05/202305:05GLOBEVirios Therapeutics Regains Compliance with Nasdaq Minimum..
15/05/202320:05GLOBEVirios Therapeutics Announces Submission of Final Toxicology..
11/05/202320:05GLOBEVirios Therapeutics Announces First Quarter 2023 Financial..
04/05/202320:05GLOBEVirios Therapeutics to Report First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock